Aeterna Zentaris Announces Final Settlement of Previously Disclosed Class-Action Lawsuit
03 juin 2021 08h05 HE
|
Aeterna Zentaris Inc
CHARLESTON, S.C., June 03, 2021 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and...
Processa Pharmaceuticals Announces Third Quarter 2020 Results, Provides Corporate Update
12 nov. 2020 17h02 HE
|
Processa Pharmaceuticals Inc.
HANOVER, MD., Nov. 12, 2020 (GLOBE NEWSWIRE) -- via InvestorWire -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) (“Processa” or the “Company”), a clinical-stage biopharmaceutical company focused on...